Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Announces NARCAN® Nasal Spray Approved by Health Canada
05 oct. 2016 08h05 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
Opiant Pharmaceuticals to Present at the Rodman & Renshaw Conference on September 13 in New York City
18 août 2016 08h45 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
Opiant Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2016 Financial Results and Provides Corporate Update
09 juin 2016 08h00 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
Opiant Pharmaceuticals, Inc. Announces Appointments of Gabrielle A. Silver, M.D., and Ann MacDougall to Board of Directors
12 mai 2016 08h00 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Submits New Drug Submission for Naloxone Nasal Spray to Health Canada
06 mai 2016 08h30 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
Opiant Pharmaceuticals, Inc., Reports Fiscal Second Quarter 2016 Financial Results and Provides Corporate Update
16 mars 2016 08h30 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
Opiant Pharmaceuticals, Inc., Announces Ticker Symbol Change to “OPNT”
07 mars 2016 16h05 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for...
Opiant Pharmaceuticals, Inc., Receives $2.5 Million Milestone Payment Following Adapt Pharma Limited’s First Commercial Sale of NARCAN® (Naloxone Hydrochloride) Nasal Spray in the U.S.
07 mars 2016 08h00 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for...
Opiant Pharmaceuticals, Inc., Convenes Medical Advisory Board to Support Development of Pharmacological Treatments for Substance Use, Addictive and Eating Disorders
17 févr. 2016 08h45 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Announces Name Change to Opiant Pharmaceuticals, Inc.
17 févr. 2016 08h30 HE
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...